Transition to Adulthood Through Coaching and Empowerment in Rheumatology
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Autoimmune Diseases
Related studies linked through entity extraction aliases.
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases
- Status
- COMPLETED
- Phase
- NA
A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE2
CAR-T Cells Targeting Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Group Education Trial to Improve Transition for Parents of Adolescents With T1D
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)
- Status
- COMPLETED
- Phase
- PHASE1
Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination
- Status
- UNKNOWN
- Phase
- N/A
Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases
- Status
- UNKNOWN
- Phase
- N/A
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
- Status
- RECRUITING
- Phase
- N/A
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
- Status
- RECRUITING
- Phase
- N/A
The Pathogenesis of Depression - Possible Autoimmune Mechanisms
- Status
- RECRUITING
- Phase
- N/A
Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D
- Status
- COMPLETED
- Phase
- PHASE1
To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.
- Status
- UNKNOWN
- Phase
- PHASE1
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
- Status
- RECRUITING
- Phase
- N/A
Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies
- Status
- COMPLETED
- Phase
- N/A
Montreal Immune-Related Adverse Events (MIRAE) Study
- Status
- RECRUITING
- Phase
- N/A
To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement
- Status
- UNKNOWN
- Phase
- PHASE1